Stocks rise amid investors’ tug of war between hope, fear

Stocks ended higher, shaking off a weak start and nearly erasing the S&P 500’s losses for the week

NEW YORK — Stocks ended higher, shaking off a weak start and nearly erasing the S&P 500′s losses for the week. The index rose 0.4% Thursday. Major indexes had wavered for much of the day as Wall Street’s tug of war continues between worries about the worsening pandemic and optimism that a vaccine will come soon. The S&P 500 fell 1.2% a day earlier, and set a record high on Monday. A discouraging report on jobless claims underscored the fears that have slowed Wall Street’s big rally this month. It showed more workers filed for unemployment benefits last week than expected.

THIS IS A BREAKING NEWS UPDATE: AP’s earlier story appears below.

U.S. stock indexes are modestly higher Thursday as Wall Street’s tug of war continues between worries about the worsening pandemic in the present and optimism that a vaccine will rescue the economy in the future.

The S&P 500 was up 0.3% in afternoon trading after spending much of the day flipping between small losses and gains. It follows up on a 1.2% slide from the day before, as the benchmark index backed away from its record of 3,626.91 set on Monday.

The Dow Jones Industrial Average was headed higher after having been down most of the day. It was up 10 points, or less than 0.1%, at 29,499 as of 3:21 p.m. Eastern time, and the Nasdaq composite was 0.8% higher.

Despite the afternoon burst of buying, the S&P 500 is still on track for its first weekly decline in three weeks. Wall Street’s huge November rally has slowed this week as fears about the economy buckling in the near term collide with hopes that stronger growth will arrive next year once effective coronavirus vaccines become available. A discouraging report on Thursday underscored the fears, showing that more U.S. workers filed for unemployment benefits last week than the week before. It was a worse number than economists expected and the first increase in five weeks.

With infections and hospitalizations on the rise across much of the country, governors and mayors are grudgingly issuing mask mandates, limiting the size of gatherings, banning indoor restaurant dining, closing gyms and restricting the hours and capacity of other businesses.

“Good vaccine news is battling worsening coronavirus trends,” said Ross Mayfield, investment strategist at Baird. “We’re at this point where you have the endgame in sight, but the path to get there looks really murky.”

Investors worry the moves and the worsening pandemic that caused them will hurt corporate profits and shake confidence among consumers, keeping them hunkered at home. New York City’s announcement that it’s halting in-person learning at public schools helped send stocks on their late-day slide Wednesday.

Democrats and Republicans in Washington, meanwhile, are still stymied in their attempts to deliver another dose of financial support to workers and businesses. That has the specter of a bleak winter looming for both the health care system and economy.

Counterbalancing all those fears is hope that coming vaccines can control the pandemic and get the global economy back toward normal next year.

“The market is grappling with the push and pull of the progress with the vaccine track, which allows a window to when our economy can reopen, with the current reality of rising cases,” said Bill Northey, senior investment director at U.S. Bank Wealth Management.

University of Oxford scientists expect to report results from the late-stage trials of the COVID-19 vaccine they’re developing with AstraZeneca by Christmas, a key researcher said Thursday.

Already this month, pharmaceutical companies have offered data suggesting other vaccines under development could be highly effective. Pfizer and BioNTech said Wednesday they plan to ask U.S. regulators within days to allow emergency use of their vaccine.

That had led to a resurgence of interest for stocks that stand to gain the most from a healthy, reopening economy. These were also among the stocks most beaten down by the stay-at-home economy created by the pandemic, such as travel-related businesses, banks and smaller companies.

Investors will likely need more clarity on the timing and impact of a vaccine in order to gain more confidence in the economic recovery, Northey said.

“We saw a sharp recovery to date, but now its beginning to plateau,” he said. “We’re doing that as we head into a very important holiday shopping season.”

A majority of stocks in the S&P 500 were higher in Thursday afternoon trading.

On the winning side of the market was L Brands, the company behind Bath & Body Works and Victoria’s Secret. It jumped 16.5% after reporting profit for the latest quarter that blew past Wall Street’s expectations.

Nvidia recovered from an early slide and was up 0.4% after reporting a stronger quarterly profit than analysts expected and offering a better-than-expected forecast for the current quarter. The stock had surged 128.3% in 2020 through Wednesday.

European stock markets fell. The French CAC 40 gave up 0.7% and Germany’s DAX lost 0.9%. The FTSE 100 in London dropped 0.8%.

In Asia, markets were mixed. Japan’s Nikkei 225 fell 0.4%, Hong Kong’s Hang Seng lost 0.7% and South Korea’s Kospi inched up by 0.1%. Stocks in Shanghai added 0.5%.

The yield on the 10-year Treasury dipped to 0.85% from 0.86% late Wednesday.

———

AP Business Writer Joe McDonald contributed.